HCA Healthcare Reports Strong Second Quarter 2024 Results

Financial Performance Highlights

HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading healthcare providers, has reported robust financial results for the second quarter ended June 30, 2024. The company demonstrated significant growth across key metrics, solidifying its position in the healthcare sector 1

1

Revenues for the quarter reached $16.528 billion, marking a 6.7% increase from $15.497 billion in the same period of the previous year. This growth reflects the company's ability to expand its services and attract more patients 2

2

Earnings and Profitability

HCA Healthcare reported a net income attributable to the company of $1.198 billion, or $4.29 per diluted share, for the second quarter of 2024. This represents a substantial improvement from $1.155 billion, or $3.90 per diluted share, in the second quarter of 2023 1

1

The company's Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) also saw an uptick, reaching $3.253 billion compared to $3.042 billion in the same quarter of the previous year 2

2

Patient Volume and Operational Metrics

HCA Healthcare experienced growth in patient volumes across various categories. Same facility admissions increased by 3.4% compared to the prior year's quarter, while same facility equivalent admissions rose by 4.4% 1

1

Emergency room visits saw a significant boost, with same facility emergency room visits increasing by 5.6%. Additionally, same facility inpatient surgeries grew by 2.0%, and same facility outpatient surgeries increased by 2.4% 2

2

Related Stories

Elevance Health Reports Strong Second Quarter 2024 Results, Raises Full Year Outlook

C.H. Robinson and Cross Country Healthcare Report Q2 2024 Financial Results

Q2 2024 Financial Results: iHeartMedia, Outbrain, and GoHealth Show Mixed Performance

Q2 2024 Financial Results: A Mixed Bag for Tech and Healthcare Companies

Strategic Initiatives and Outlook

Samuel N. Hazen, Chief Executive Officer of HCA Healthcare, expressed satisfaction with the company's performance, stating, "We are pleased with our second quarter results and the continued strong demand for our services." He emphasized the company's focus on investing in its colleagues, clinical programs, and technology to support growth and improve patient care 1

1

The company also updated its guidance for the full year 2024, projecting revenues between $65.5 billion and $66.5 billion, and adjusted EBITDA in the range of $12.9 billion to $13.3 billion 2

2

Capital Allocation and Shareholder Returns

During the quarter, HCA Healthcare repurchased 3.453 million shares of its common stock for approximately $1.050 billion. As of June 30, 2024, the company had $2.825 billion remaining under its repurchase authorization 1

1

The company's board of directors also declared a quarterly cash dividend of $0.66 per share on the company's common stock, payable on September 29, 2024, to stockholders of record at the close of business on September 16, 2024 2

2

HCA Healthcare's strong second quarter results demonstrate its resilience and ability to grow in a challenging healthcare landscape, positioning the company for continued success in the future.